The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53.
about
p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma.Targeting p53 by small molecules in hematological malignancies.Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.Preeclampsia is associated with alterations in the p53-pathway in villous trophoblast.Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways.Persistent p21 expression after Nutlin-3a removal is associated with senescence-like arrest in 4N cells.The IGF-1R/AKT pathway determines cell fate in response to p53.PUMA protein in p53 regulatory molecule pattern determines the prognosis for patients with lymphoproliferative diseases.The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability.
P2860
Q34547830-5849A478-8B94-4762-AE70-8FD205F10BFCQ34636996-1F20E978-1C17-42CA-9746-6DAF4562E14BQ34982229-1AA12390-7D40-4358-8EA4-A8AFC6CE2B91Q35762274-870A8FEB-29DD-487E-8884-A72BBD9BCA2EQ35909637-D4E24FBA-A1B5-42C6-BFB6-2C63D17140B1Q36100952-F9391BD4-97B0-44AE-B0FC-1AAF62298010Q37534671-3BFF2284-C778-4460-8BB9-0BCAD7612855Q39685958-73721B95-1F18-407A-9B9E-9F03C78F0F32Q39701774-73BA7F1B-9AED-43BE-B975-0F268F8AF343Q41687394-B489DA47-C975-4380-BAF6-EC36407E05EAQ48864176-40BECEFD-1438-4273-BFCA-F49CB381AC3EQ52671466-C30D4338-D785-4D25-A35E-CF40FCDED9BA
P2860
The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The therapeutic potential of p ...... with wild-type or mutated p53.
@en
The therapeutic potential of p ...... with wild-type or mutated p53.
@nl
type
label
The therapeutic potential of p ...... with wild-type or mutated p53.
@en
The therapeutic potential of p ...... with wild-type or mutated p53.
@nl
prefLabel
The therapeutic potential of p ...... with wild-type or mutated p53.
@en
The therapeutic potential of p ...... with wild-type or mutated p53.
@nl
P2093
P2860
P356
P1433
P1476
The therapeutic potential of p ...... with wild-type or mutated p53.
@en
P2093
E Schlette
G Z Rassidakis
I Papanastasi
L J Medeiros
P2860
P2888
P304
P356
10.1038/LEU.2009.180
P577
2009-09-10T00:00:00Z